Projects

1 - 10 of 560 results

Search term:

COVID19 – TriVoice PLUS – Astra-Zeneca derde dosis, Vaccination against Covid-19 in cancer: booster shot BNT161b2 vaccine after full vaccination with ChAdOx1-S vaccine (Tri-VOICE plus). University of Antwerp

Eva Lion
Laboratory for Experimental Hematology (LEH)
COVID-19 is a disease caused by an infectious outbreak of SARS-CoV-2. This viral SARS-CoV-2 infection can present itself in a broad spectrum of clinical features, ranging from asymptomatic, sensation of a mild cold or flu to severe bilateral pneumonia and death. Cancer patients are at high risk to develop serious illness after infection with SARS-CoV-2. Therefore, it is of high importance to protect these patients by following hygiene ...

COVID19 - TriVoice –derde dosis, Vaccination against Covid-19 In cancer patients under active treatment (Belgium, B-VOICE) University of Antwerp

Eva Lion
Laboratory for Experimental Hematology (LEH)
COVID-19 is a disease caused by an infectious outbreak of SARS-CoV-2. This viral SARS-CoV-2 infection can present itself in a broad spectrum of clinical features, ranging from asymptomatic, sensation of a mild cold or flu to severe bilateral pneumonia and death. Cancer patients are at high risk to develop serious illness after infection with SARS-CoV-2. Therefore, it is of high importance to protect these patients by following hygiene ...

COVID19 - ONCO-VAC, Vaccination against Covid-19 in cancer patients under active treatment (Belgium, B-VOICE) University of Antwerp

Eva Lion
Laboratory for Experimental Hematology (LEH)
COVID-19 is a disease caused by an infectious outbreak of SARS-CoV-2. This viral SARS-CoV-2 infection can present itself in a broad spectrum of clinical features, ranging from asymptomatic, sensation of a mild cold or flu to severe bilateral pneumonia and death. Cancer patients are at high risk to develop serious illness after infection with SARS-CoV-2. Therefore, it is of high importance to protect these patients by following hygiene ...

The more you tell me how and why to avoid spreading COVID-19, the more I feel I can spare myself the trouble. Enhancing compliance with measures against COVID-19 by counteracting side-effects of appeals for preventive behaviour. Hasselt University

Centre for Statistics
To curb the toll of COVID-19, citizens need to massively comply with precautionary measures. Once a vaccine will be available that compliance will mostly consist of getting vaccinated. Until then, it consists of things like wearing a mouth mask and social distancing. Since the start of the first COVID-19 outbreak in Belgium, however, our country has witnessed a decline of people's motivation to show those behaviours. Why have some people ...

The more you tell me how and why to avoid spreading COVID-19, the more I feel I can spare myself the trouble. Enhancing compliance with measures against COVID-19 by counteracting side-effects of appeals for preventive behaviour. KU Leuven

Vera Hoorens
Methods, Individual and Cultural Differences, Affect and Social Behavior, Leuven Biostatistics and Statistical Bioinformatics Centre (L-BioStat), Sciensano, Universiteit Hasselt

To curb the toll of COVID-19 , citizens need to massively comply with precautionary measures. Once a vaccine will be available that compliance will mostly consist of
getting vaccinated. Until then, it consists of things like wearing a mouth mask and social distancing. Since the start of the first COVID-19 outbreak in Belgium, however, our country has witnessed a decline of people's motivation to show those behaviours. Why have some ...

INFECT: exploratIoN oF (epi)-gEnetic changes Contributing To long COVID-19 KU Leuven

Peter Carmeliet
Laboratory of Angiogenesis and Vascular Metabolism (VIB-KU Leuven)

SARS-CoV-2 has been rapidly spreading around the globe counting >55million infections and >1 million deaths, with continuously rising numbers. A sizable fraction of infected subjects develops viral pneumonia with signs of acute respiratory distress syndrome, which – in severe cases – leads to respiratory failure and death. While tremendous efforts are made to probe the underlying molecular mechanisms of acute COVID-19 disease (SHORT ...

Retraining of traving dogs for the detection of COVID-19 human patients Ghent University

Frank Gasthuys
Department of Large Animal Surgery, Anaesthesia and Orthopaedics

During the first outbreak of COVID-19 in Europe begin 2020, Prof. Dr. Dominique Grandjean from the faculty of veterinary medicine Maison Alfort but also colonel in the fire brigade, Paris, took the initiative to investigate if tracing dogs could made the difference between CPVID 19 – and + patients using sweat samples obtained from the inguinal and armpits regions (30 minutes of sampling). Since the virus is not excreted in sweat, this was ...

The added value of point-of-care testing in nursing homes during the COVID-19 pandemic KU Leuven

Jan Verbakel
Academic Center for General Practice

My PhD will mainly focus on the COVID-19 pandemic. At the end of December 2019, several cases of pneumonia of an unknown origin were reported in Wuhan, China. Not long after, they were declared to be caused by the SARS-CoV-2 virus. The virus started to spread quickly and on the 11th of March 2020, the WHO declared the outbreak as a pandemic. The COVID-19 pandemic had a devastated impact in many nursing homes. Numerous nursing homes in Belgium ...

Immunogenicity after COVID-19 vaccines in adapted schedules (IMCOVAS). University of Antwerp

Katie Steenackers
Centre for the Evaluation of Vaccination (CEV)
Assessment of the immunogenicity and safety of marketed vaccines for COVID-19 after regular schedule and adapted vaccine schedules and routes: BNT162b2 (Comirnaty®; Pfizer-BioNTech), mRNA-1273 Vaccine (COVID-19 Vaccine Moderna®; Moderna) and COVID-19 Vaccine (ChAdOx1-S [recombinant]) (Vaxzevria®, AstraZeneca). A A prospective, post marketing, randomized, partially single blind, multicenter, interventional study in 560 healthy adults 18-55y Most ...